AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ASTRAZEN and BSE: 506820 (ISIN INE203A01020).
It has a market capitalisation of ₹15,099 crore, a last close of ₹6,040 on 2026-10-19, a one-year return of -34.2%.
Valuation: a price-to-earnings ratio of 89.02x, a price-to-book ratio of 17.30x, a dividend yield of 0.6%.
Profitability: return on equity of 22.8%, return on capital employed of 28.2%, an operating margin of 9.5%.
Growth: sales growth of 31.4% a year over three years, net profit growth of 23.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 75.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 15,099 |
| Last close | ₹6,040 |
| P/E (TTM) | 89.02x |
| P/B | 17.30x |
| Dividend yield | 0.6% |
| ROE (FY) | 22.8% |
| ROCE (FY) | 28.2% |
| Operating margin (TTM) | 9.5% |
| Sales growth, 3-year CAGR | 31.4% |
| Profit growth, 3-year CAGR | 23.6% |
| Debt / equity | 0.00x |
| Promoter holding | 75.0% |
| 1-year return | -34.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means